57 studies found for:    "GW433908"[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
21 Completed GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: GSK1349572;   Drug: Fosamprenavir;   Drug: Ritonavir
22 Completed Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Intervention: Drug: No intervention; Observational study
23 Completed Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
Condition: HIV Infections
Interventions: Drug: Fosamprenavir;   Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate
24 Completed
Has Results
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: Efavirenz 600mg;   Drug: Boosted Lexiva
25 Completed Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)
Condition: HIV Infections
Interventions: Drug: Fosamprenavir;   Drug: Saquinavir
26 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
27 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition: HIV Infections
Interventions: Drug: lopinavir;   Drug: atazanavir;   Drug: efavirenz;   Drug: fosamprenavir;   Drug: darunavir;   Drug: tipranavir;   Drug: ritonavir;   Drug: nevirapine;   Drug: zidovudine;   Drug: lamivudine;   Drug: tenofovir;   Drug: emtricitabine;   Drug: abacavir
28 Completed PENTA Fosamprenavir Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
29 Completed
Has Results
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Interventions: Drug: ATV/r;   Drug: DRV/r
30 Terminated Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects
Condition: HIV-1
Interventions: Drug: fosamprenavir/ritonavir (700mg/100mg BID);   Drug: fosamprenavir/ritonavir (1400mg/100mg BID);   Drug: fosamprenavir/lopinavir/ritonavir (1400mg/533mg/100mg BID)
31 Completed A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203);   Biological: Aluminum hydroxide;   Biological: MF59;   Biological: rgp120/HIV-1MN
32 Completed
Has Results
Fosamprenavir in Pts With Hepatic Impairment
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Intervention A Standard dose;   Drug: Intervention B Reduced Dose;   Drug: Intervention C;   Drug: Intervention D;   Drug: Intervention E
33 Completed Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV
Condition: HIV Infections
Interventions: Drug: lopinavir/ritonavir;   Drug: indinavir sulfate;   Drug: tenofovir disoproxil fumarate;   Drug: ritonavir;   Drug: fosamprenavir
34 Completed
Has Results
Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: Study NNRTI;   Drug: Study PI
35 Completed A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir
Condition: HIV Infections
Intervention: Drug: Indinavir/Ritonavir/Fosamprenavir
36 Completed
Has Results
Clinical Trial of CNS-targeted HAART (CIT2)
Condition: HIV Infections
Intervention: Drug: FDA Approved Antiretroviral Therapy (see list below)
37 Completed A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
Condition: HIV
Interventions: Drug: fos-amprenavir calcium, ritonavir;   Drug: abacavir/lamivudine as Epzicom
38 Active, not recruiting MARCH Renal Substudy
Conditions: Proteinuria;   HIV
Interventions: Drug: arm 1 nucleotide analogue reverse transcriptase inhibitors and boosted protease inhibitors;   Drug: Arm 2 boosted protease inhibitors and maraviroc;   Drug: Arm 3 nucleotide analogue reverse transcriptase inhibitors and maraviroc
39 Active, not recruiting MARCH Central Nervous System Substudy
Condition: HIV-1 Infection
Interventions: Drug: Arm 1 TNucleotide Analogue Reverse Transcriptase Inhibitors and Boosted Protease Inhibitors;   Drug: Arm 2 Maraviroc and Protease Inhibitors;   Drug: Arm 3 Maraviroc and Nucleotide Analogue Reverse Transcriptase Inhibitors
40 Completed VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.
Conditions: Hepatitis C;   Telaprevir;   HIV
Intervention: Drug: Telaprevir; Darunavir; Ritonavir; Fosamprenavir

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results
Indicates status has not been verified in more than two years